DIAMOND HILL CAPITAL MANAGEMENT INC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 195 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIAMOND HILL CAPITAL MANAGEMENT INC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$222,020
-19.7%
28,5740.0%0.00%0.0%
Q2 2023$276,596
-11.7%
28,5740.0%0.00%0.0%
Q1 2023$313,171
+153.7%
28,5740.0%0.00%0.0%
Q4 2022$123,440
-42.6%
28,5740.0%0.00%0.0%
Q3 2022$215,000
-25.1%
28,5740.0%0.00%0.0%
Q2 2022$287,000
-18.9%
28,5740.0%0.00%0.0%
Q1 2022$354,000
-19.4%
28,574
+48.9%
0.00%
-50.0%
Q4 2021$439,000
+7.3%
19,184
+3.9%
0.00%0.0%
Q3 2021$409,000
+71.1%
18,4690.0%0.00%
+100.0%
Q2 2021$239,00018,4690.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders